Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation

被引:417
作者
Shimaoka, M
Xiao, T
Liu, JH
Yang, YT
Dong, YC
Jun, CD
McCormack, A
Zhang, RG
Joachimiak, A
Takagi, J
Wang, JH
Springer, TA
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA
[8] Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA
[9] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA
关键词
D O I
10.1016/S0092-8674(02)01257-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structure of the I domain of integrin alphaLbeta2 bound to the Ig superfamily ligand ICAM-1 reveals the open ligand binding conformation and the first example of an integrin-IgSF interface. The I domain Mg2+ directly coordinates Glu-34 of ICAM-1, and a dramatic swing of I domain residue Glu-241 enables a critical salt bridge. Liganded and unliganded structures for both high- and intermediate-affinity mutant I domains reveal that ligand binding can induce conformational change in the alphaL I domain and that allosteric signals can convert the closed conformation to intermediate or open conformations without ligand binding. Pulling down on the C-terminal alpha7 helix with introduced disulfide bonds ratchets the beta6-alpha7 loop into three different positions in the closed, intermediate, and open conformations, with a progressive increase in affinity.
引用
收藏
页码:99 / 111
页数:13
相关论文
共 58 条
[21]   The Immunological Synapse: A Molecular Machine Controlling T Cell Activation [J].
Grakoui, Arash ;
Bromley, Shannon K. ;
Sumen, Cenk ;
Davis, Mark M. ;
Shaw, Andrey S. ;
Allen, Paul M. ;
Dustin, Michael L. .
JOURNAL OF IMMUNOLOGY, 2015, 194 (09) :221-227
[22]   MODEL BIAS IN MACROMOLECULAR CRYSTAL-STRUCTURES [J].
HODEL, A ;
KIM, SH ;
BRUNGER, AT .
ACTA CRYSTALLOGRAPHICA SECTION A, 1992, 48 :851-858
[23]   A BINDING INTERFACE ON THE I-DOMAIN OF LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 (LFA-1) REQUIRED FOR SPECIFIC INTERACTION WITH INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) [J].
HUANG, CC ;
SPRINGER, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19008-19016
[24]   Integrin affinity modulation [J].
Hughes, PE ;
Pfaff, M .
TRENDS IN CELL BIOLOGY, 1998, 8 (09) :359-364
[25]   NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding [J].
Huth, JR ;
Olejniczak, ET ;
Mendoza, R ;
Liang, H ;
Harris, EAS ;
Lupher, ML ;
Wilson, AE ;
Fesik, SW ;
Staunton, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5231-5236
[26]   Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain [J].
Kallen, J ;
Welzenbach, K ;
Ramage, P ;
Geyl, D ;
Kriwacki, R ;
Legge, G ;
Cottens, S ;
Weitz-Schmidt, G ;
Hommel, U .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 292 (01) :1-9
[27]   CRITICAL THREONINE AND ASPARTIC-ACID RESIDUES WITHIN THE I-DOMAINS OF BETA-2 INTEGRINS FOR INTERACTIONS WITH INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) AND C3BI [J].
KAMATA, T ;
WRIGHT, R ;
TAKADA, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (21) :12531-12535
[28]  
KOOPMAN G, 1994, J IMMUNOL, V152, P3760
[29]   MOLSCRIPT - A PROGRAM TO PRODUCE BOTH DETAILED AND SCHEMATIC PLOTS OF PROTEIN STRUCTURES [J].
KRAULIS, PJ .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :946-950
[30]   STRUCTURE AND FUNCTION OF LEUKOCYTE INTEGRINS [J].
LARSON, RS ;
SPRINGER, TA .
IMMUNOLOGICAL REVIEWS, 1990, 114 :181-217